COMBINED OSTEOPOROSIS TREATMENT WITH ANTIRESORPTIVE ALENDRONATE PLUS PLEIOTROPICALLY ACTING ALFACALCIDOL: RATIONALE AND CLINICAL EVIDENCE

被引：0

作者：

Ringe, J. ^{[1
,2
]}

Schacht, E. ^{[3
]}

机构：

[1] Univ Cologne, Med Clin 4, Klinikum Leverkusen, Leverkusen, Germany

[2] W German Osteoporosis Ctr, Leverkusen, Germany

[3] Zorg Int Zurich Osteoporosis Res Grp, Zollikerberg, Switzerland

来源：

OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：39 / 39

页数：1

共 50 条

[1] Superiority of a combined treatment of alfacalcidol and alendronate compared to the monotherapies in postmenopausal osteoporosis
不详
[J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S151 - S151
[2] Superiority of a combined treatment of alfacalcidol and alendronate compared to the monotherapies in postmenopausal osteoporosis
Ones, K.
Schacht, E.
[J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S20 - S20
[3] Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial
Lufkin, EG
Sarkar, S
Kulkarni, PM
Ciaccia, AV
Siddhanti, S
Stock, J
Plouffe, L
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) : 351 - 357
[4] Antifracture efficacy of combined treatment with alendronate and alfacalcidol for osteoporosis in early-phase treatment
Miyakoshi, N.
Kasukawa, Y.
Kodama, H.
Noguchi, H.
Sasaki, H.
Kamo, K.
Shimada, Y.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S341 - S341
[5] Combined treatment with alendronate plus, alfacalcidol in established postmenopausal or male osteoporosis: A prospective, randomised controlled trial.
Ringe, J. D.
Faber, H.
Fahramand, P.
Dorst, A.
Schacht, E.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S308 - S309
[6] Superiority of a combined treatment of alfacalcidol and alendronate compared to the respective monotherapies in established osteoporosis
Ringe, J. D.
Farahmand, P.
Schacht, E.
[J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S238 - S238
[7] Alendronate treatment for osteoporosis: A review of the clinical evidence
Selby, P
[J]. OSTEOPOROSIS INTERNATIONAL, 1996, 6 (06) : 419 - 426
[8] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
Ringe, J. D.
Farahmand, P.
Schacht, E.
Rozehnal, A.
[J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 425 - 434
[9] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
J. D. Ringe
P. Farahmand
E. Schacht
A. Rozehnal
[J]. Rheumatology International, 2007, 27 : 425 - 434
[10] COMBINED TREATMENT WITH ALENDRONATE AND ALFACALCIDOL COMPARING WITH OTHER BISPHOSPHONATES AND ALFACALCIDOL IN BMD CHANGES
Galesanu, Corina
Ancute, Petronela
Zaharia, Valentin
Mocanu, Veronica
Galesanu, Mihai-Romeo
[J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S129 - S130

← 1 2 3 4 5 →